Skip to main content
  • Research article
  • Open access
  • Published:

The role of alcohol in the management of hypertension in patients in European primary health care practices – a survey in the largest European Union countries



Even though addressing lifestyle problems is a major recommendation in most guidelines for the treatment of hypertension (HTN), alcohol problems are not routinely addressed in the management of hypertension in primary health care.


Internet based survey of 3081 primary care physicians, recruited via the mailing lists of associations for general practitioners (GPs) in France, Germany, Italy, Spain and the UK. Clinical practice, attitudes, knowledge, education and training were assessed. Logistic regression to predict screening, brief intervention and treatment for alcohol dependence in the management of hypertension were assessed.


Overall, about one third of the interviewed GPs reported sufficient screening in cases with HTN (34.0 %, 95 % confidence interval (CI):32.1–35.8 %). One out of five GPs screened and delivered brief interventions in HTN patients with hazardous consumption (22.2 %, 95 % CI: 20.6–23.8 %) and about one in 13 GPs provided treatment for HTN patients with alcohol dependence other than advice or brief intervention (7.8 %, 95 % CI: 6.8–8.9 %). Post-graduate training and belief in their effectiveness predicted interventions. There were marked differences between countries.


While current interventions were overall low, marked differences between countries indicate that current practices could be improved. Education and post-graduate training seems to be key in improving clinical practice of including interventions for problematic alcohol consumption and alcohol dependence in primary health care.

Peer Review reports


Hypertension (HTN) is the single most important risk factor for mortality and burden of disease, globally and especially for high income countries in Europe [1]. Its main effect is on cardiovascular outcomes, and consequently, reduction of blood pressure is among the risk factor targets of the World Health Organisation ‘Global Action Plan for Prevention and Control of Non-communicable Diseases’ for the period 2013–2020 [2]. Primary health care has traditionally had a key role in the detection and the management of HTN [3]. Part of this management involves advice and interventions on lifestyle factors underlying HTN, and guidelines recommend lifestyle changes as important means to reduce blood pressure, prevent and/or avoid medication for HTN [35]. Both epidemiology and randomized trials converge in demonstrating that alcohol consumption, in particular heavy drinking, is one of the most important lifestyle based risk factors for HTN [69].

However, the mortality and disease burden attributable to HTN has increased globally since 1990 [1] and large European surveys still show a large proportion of adults with uncontrolled HTN (, indicating the need for further action. Of all lifestyle factors, alcohol seems to be the least intervened in the management of HTN [1013], which is no surprise given the low screening and intervention rates for hazardous drinking and alcohol use disorder in primary health care [14, 15]. Interventions for hazardous drinking are scarce [1517]; and alcohol use disorders have the lowest treatment rate of all mental disorders [1820], despite evidence that there are effective interventions available for both hazardous drinking and for alcohol use disorders [21, 22], which could be implemented at the primary care level [23, 24].

Thus, improving alcohol interventions in primary health care promises to yield substantial health benefits [1013, 25]. The main question to realize this potential is how to best implement such interventions [23], both for hazardous drinking and for alcohol use disorders, as part of routine management of HTN. Together with primary care associations in the five largest countries in the European Union (France, Germany, Italy, Spain, and the United Kingdom (UK)), we developed a survey of general practitioners (GPs) to explore knowledge, attitudes and clinical practice of lifestyle interventions in the management of HTN and to help a potential implementation of alcohol interventions (Baseline Alcohol Screening and Intervention Survey (BASIS)).


Design of the BASIS survey and pilot

All authors were involved in drafting and finalizing the survey, originally in English. After an empirical pilot study in five countries (N = 41 respondents), the survey was translated into French, German, Italian, and Spanish and the national versions were again tested and finalized with the help of local experts. A brief summary of the survey and its subsections are given in Additional file 1. It contained 28 core items (in addition to a few country-specific items) and was put online in all languages using SurveyMonkey ( The English version of the survey can be found online (Additional file 2). The theoretical basis was the Information-Motivation-Behavioural Skills model [26, 27], which stipulates that information and education is not sufficient to adopt behaviours; in addition there needs to be motivation and behavioural skills. This model had been adopted to care of non-communicable diseases [28].

Survey implementation

In each of the five countries, regional or nationwide GP associations disseminated the web link to the survey to their members, mainly via electronic mail (for details see Table 1). The median completion time was 8.8 min, with a span from under 2 min to over an hour). Four responses were removed from the data set due to suspicion of being duplicates. The entire survey was answered by 2468 respondents (80.1 % of those who started: 3081) between September 29 and December 1, 2015.

Table 1 Assessment details by country

The survey included a number of free text items, including descriptions how alcohol problems were managed. A coding scheme based on free text responses given in Germany and the UK was developed and subsequently all such responses were classified by two independent raters for each language. Kappa agreement coefficients were calculated and ranged from 0.31 to 1 in the variables analyzed. Non-concordant ratings were revisited and a final decision was made by JM.

Statistical analyses

Three different indicators for good practice alcohol management in patients with HTN were derived from responses given in the questionnaire: a) sufficient screening for alcohol use (at least 7 out of 10 HTN patients); b) sufficient screening (as above) in addition to management of alcohol problems in hypertensive patients with hazardous drinking levels by the GP themselves or within the same practice usually with brief interventions (for rationale see care [21, 29]; c) sufficient screening and management of alcohol dependence in hypertensive patients by the GPs themselves or within the same practice. Indicator c was only met if GPs did not only offer brief advice or counselling as management for alcohol dependence but also reported other interventions, such as psychotherapy, or pharmacotherapy. This operationalization was chosen, as current guidelines do not recommend brief advice only as a treatment intervention for dependence [30, 31].

Logistic regressions on each indicator were computed with Stata 14.0 [32], using the following variables as covariates (specifications in parentheses): age (categories as dummy variables with ‘70 or older’ as reference category), sex, country (dummy coded with UK as reference category), beliefs about success of different lifestyle interventions for hypertension (questionnaire items 3 and 4: dummy variables, each scored 1 if rated (highly) successful, else 0), knowledge (questionnaire item 1: dummy variable, scored 1 if alcohol was selected as important risk factor for HTN, else 0), education (questionnaire items 24 and 27: dummy variables, each scored 1 for at least 4 out of 5 points on Likert scale regarding adequacy of graduate education on alcohol/HTN, else 0; questionnaire items 25 and 28: dummy variables, each scored 1 if post-graduate education on alcohol, HTN was received, else 0), and workload (questionnaire item 7: continuous variable containing number of daily patient contacts, z-standardized for each country to achieve comparability). A measure of the respondents’ drinking patterns (questionnaire items 32–34) was also considered for inclusion in the models. However, it was decided against it as it would have overly limited the generalizability of the findings by reducing the sample size by 24 % (from 2468 to 1885) because these items were not assessed among UK respondents and responses were not required to complete the survey in the remaining countries.


Two thousand four hundred sixty eight health professionals participated in the survey (for details see Table 1).

With respect to the indicators of good practice alcohol management (= main dependent variables), Table 2 gives the prevalence by country.

Table 2 Good practice alcohol management by country

The overview of influencing variables for good practice alcohol management are given in Table 3, where the reference country was always the UK. Clearly screening for alcohol was best implemented in the UK and Spain, management of hazardous drinking levels was best implemented in Spain (87 % of all identified GPs treated only via brief interventions/advice), and treatment of alcohol dependence was best implemented in Spain and Germany. As hypothesized, post-graduate education and the belief that lifestyle interventions were successful in avoiding HTN-related prescriptions seem to impact on all three indicators. For screening and management of hazardous drinking levels, the GPs’ knowledge about the importance of alcohol as a risk factor for HTN was also positively related.

Table 3 Prediction of good practice alcohol management


In this large survey, we found that alcohol interventions were relatively scarce in European primary health care. Overall, about one third of the interviewed GPs reported sufficient screening in cases with HTN. One out of five GPs screened and delivered brief interventions in HTN patients with hazardous consumption and about one of 13 GPs provided treatment for HTN patients with alcohol dependence other than advice or brief intervention. There were marked differences between European countries though, with most of the screening and interventions been given in Spain and the UK, and least in France. Compared to British GPs, only a fraction of the French colleagues reported sufficient alcohol screening (OR = 0.08), and only every 50th French GP reported sufficient screening and alcohol management in alcohol dependent patients on their own. We can only speculate about the reasons for the French situation, but it may have to do with lack of guidelines. The French guidelines for HTN treatment developed in 2005 had to be withdrawn in 2011 ( as the authors’ conflict of interest statements did not meet later introduced rules ( In general, the notion of the beneficial effects of alcohol on cardiovascular outcomes is strong (“French paradox”; see [33]; see also the official training materials of the French cardiologists [34]). The lack of knowledge and training in Italian GPs with respect to screening and brief interventions has been found in several other European studies (INEBRIA: AMPHORA: [35]; see also, and has seemingly not improved over the past years.

Before we discuss potential conclusions of the results, we would like to highlight limitations. First, response rates are relatively low. While it is hard to compare response rates across physicians’ surveys, as there are different sampling frames and several web-based surveys do not even give response rates [36, 37], and even though web-based surveys have comparably lower response rates [38], an overall response rate of 6 % must be considered low. As a consequence, while the national/regional sampling frames can be considered as representative, the low response rates suggest that a convenience sample of GP’s being more motivated and interested in the topic has been drawn [39]. Thus the screening and intervention rates reported are likely to be overestimates (for intervention rates in samples of GP’s with representative sampling and a considerably higher response rate [14, 40]). Second, all answers were self-reports and social desirability bias may have shifted some of our key results upwards [41]. In other words, based on the two major limitations of this study, the rates for screening and interventions among hypertensive primary health care patients in Europe are most likely lower than described in this study. However, given the low response rate, we cannot fully rule out that we have underestimated the GPs’ involvement, e.g., if engaged GPs were too busy to participate in our survey.


While our findings are susceptible to sample distortion, they are sufficiently robust to demonstrate that the GPs’ involvement in alcohol screening and management among patients with HTN is generally poor in the largest European countries. Thus, the situation for HTN patients is likely not better than for other primary care patients with respect to detection of and interventions for heavy drinking and alcohol use disorders [14, 15, 17, 40]. What can be done about this? First, medical education at universities have to put more emphasis on alcohol as one of the main risk factors for many disease conditions GPs see in their daily practice [40]. The lack of education seems a common problem in all five countries, and was also highlighted in some of the qualitative answers. Moreover, post-graduate training was shown to increase screening and intervention rates [16, 42], and this is, where GP associations can contribute. Secondly, given the high overall workload of GPs, and the overall health burden attributable to alcohol in countries in the European Union [20], alcohol interventions need to be prioritized and this could be done by financial incentives. A recent cluster randomized trial with 746 providers in 120 primary health care centers from five European countries has shown that modest financial incentives increase screening and intervention rates. Interestingly, there is a synergistic effect when financial incentives, training and support are offered together [17]. We hope that the involvement of several GP associations in the current study will help overcome these barriers in the future.



Baseline Alcohol Screening and Intervention Survey


General practitioner




United Kingdom


  1. Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, Brauer M, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2287–323.

    Article  PubMed  Google Scholar 

  2. World Health Organization. Global Action Plan for the Prevention and Control of NCDs 2013-2020. Geneva: World Health Organization; 2013.

    Google Scholar 

  3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. JAMA. 2003;289:2560–72.

    Article  CAS  PubMed  Google Scholar 

  4. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–357.

    Article  CAS  PubMed  Google Scholar 

  5. National Institute for Health and Clinical Excellence. Hypertension in adults: diagnosis and managment. Manchester: National Institute for Health and Clinical Excellence; 2011.

    Google Scholar 

  6. O’Keefe JH, Bhatti SK, Bajwa A, DiNicolantonio JJ, Lavie CJ. Alcohol and cardiovascular health: the dose makes the poison…or the remedy. Mayo Clin Proc. 2014;89:382–93.

    Article  PubMed  Google Scholar 

  7. Taylor B, Irving HM, Baliunas D, Roerecke M, Patra J, Mohapatra S, et al. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction. 2009;104:1981–90.

    Article  PubMed  Google Scholar 

  8. Chen L, Smith GD, Harbord RM, Lewis SJ. Alcohol intake and blood pressure: A systematic review implementing a Mendelian Randomization Approach. PLoS Med. 2008;5:461–71.

    Article  CAS  Google Scholar 

  9. Xin X, He J, Frontini MG, Ogden LG, Motsamai OJ, Whelton PK. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2001;38:1112–7.

    Article  CAS  PubMed  Google Scholar 

  10. Gual A, Zarco J, Colom JF, Rehm J. Cribado precoz e intervención breve en el consumo perjudicial de alcohol para mejorar el tratamiento de la hipertensión arterial en atención primaria. Med Clin-Barcelona. 2016;146:81–5.

    Article  Google Scholar 

  11. Collart F, de Timary P, Dom G, Dor BD, Duprez D, Lengelé JP, et al. Alcohol-induced hypertension: an important healthcare target in Belgium. Acta Clin Belg. 2015;70:389–95.

    Article  PubMed  Google Scholar 

  12. Aalto M, Jula A, Keinänen-Kiukaanniemi S, Liira H, Räsänen K, Rehm J et al. Alkoholin haitallinen käyttö kohonneen verenpaineen aiheuttajana. Suomen Lääkärilehti. accepted.

  13. Rehm J, Gmel G, Kiefer F, Kreutz R, Kugler J, Müller-Walther M, et al. Verbessertes Hypertonie-Management durch Alkohol-Screening und Folgeinterventionen in der Hausarztpraxis. Deu Med Wochenschr. 2014;139:2457–62.

    Article  Google Scholar 

  14. Manthey J, Probst C, Hanschmidt F, Rehm J. Identification of smokers, drinkers and risky drinkers by general practitioners. Drug Alcohol Depend. 2015;1:93–9.

    Article  Google Scholar 

  15. Brown J, West R, Angus C, Beard E, Brennan A, Drummond C, et al. Comparison of brief interventions in primary care on smoking and excessive alcohol consumption: a population survey in England. Br J Gen Pract. 2016;66:e1–9.

    Article  PubMed  Google Scholar 

  16. Anderson P, Bendtsen P, Spak F, Reynolds J, Drummond C, Segura L, et al. Implementation science: a scientific report describing the methods, results and conclusions of the ODHIN randomized controlled trial. Barcelona: ODHIN Project; 2015.

    Google Scholar 

  17. Anderson P, Bendtsen P, Spak F, Reynolds J, Drummond C, Segura L et al. Improving the delivery of brief interventions for heavy drinking in primary health care: outcome results of the Optimizing Delivery of Health Care Intervention (ODHIN) five country cluster randomized factorial trial. Addiction. 2016;epub ahead of print.

  18. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al. Use of mental health services in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiat Scand. 2004;109:47–54.

    Article  Google Scholar 

  19. Kohn R, Saxena S, Levav I, Saraceno B. The treatment gap in mental health care. Bull World Health Org. 2004;82:858–66.

    PubMed  PubMed Central  Google Scholar 

  20. Rehm J, Shield KD, Rehm MX, Gmel G, Frick U. Modelling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur Neuropsychopharmacol. 2013;23:89–97.

    Article  CAS  PubMed  Google Scholar 

  21. Kaner EF, Beyer F, Dickinson HO, Pienaar E, Campbell F, Schlesinger C, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2007;18:CD004148.

    Google Scholar 

  22. Miller WR, Wilbourne PL, Hettema JE. What Works? A summary of alcohol treatment outcome research. In: Hester RK, Miller WR, editors. Handbook of alcoholism treatment approaches. Boston: Allyn and Bacon; 2003. p. 13–63.

    Google Scholar 

  23. Rehm J, Anderson P, Manthey J, Shield KD, Struzzo P, Wojnar M, et al. Alcohol use disorders in primary health care – what do we know and where do we go? Alcohol Alcohol. 2015;51:422–7.

    Article  PubMed  Google Scholar 

  24. Spithoff S, Kahan M. Paradigm shift: Moving the management of alcohol use disorders from specialized care to primary care. Can Fam Physician. 2015;61:495–7.

    PubMed Central  Google Scholar 

  25. Rehm J, Gmel G, Sierra C, Gual A. Reduction of mortality associated by a better detection of hypertension and alcohol problems in primary health care in Spain. Adicciones. 2016;in press.

  26. Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychol Bull. 1992;111:455–74.

    Article  CAS  PubMed  Google Scholar 

  27. Fisher JD, Fisher WA, Shuper PA. Social psychology and the fight against AIDS: An Information-Motivation-Behavioral Skills Model for the Prediction and Promotion of Health Behavior Change. Adv Exp Soc Psychol. 2014;50:105–93.

    Article  Google Scholar 

  28. Amico KR. A situated-Information Motivation Behavioral Skills Model of Care Initiation and Maintenance (sIMB-CIM): An IMB Model Based Approach to Understanding and Intervening in Engagement in Care for Chronic Medical Conditions. J Health Psychol. 2011;16:1071–81.

    Article  Google Scholar 

  29. O’Donnell A, Anderson P, Newbury-Birch D, Schulte B, Schmidt C, Reimer J, et al. The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews. Alcohol Alcohol. 2014;49:66–78.

    Article  PubMed  Google Scholar 

  30. National Institute for Health and Clinical Excellence. Alcohol use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence. London: National Institute for Health and Clinical Excellence; 2011.

    Google Scholar 

  31. Rehm J, Rehm MX, Alho H, Allamani A, Aubin H-J, Bühringer G, et al. Alcohol dependence treatment in the EU: a literature search and expert consultation about the availability and use of guidelines in all EU countries plus Iceland, Norway, and Switzerland. Int J Alcohol Drug Res. 2013;2:53–67.

    Article  Google Scholar 

  32. Corporation S. Stata Statistical Software: Release 14. College Station: Stata Corporation LP; 2015.

    Google Scholar 

  33. Biagi M, Bertelli AA. Wine, alcohol and pills: What future for the French paradox? Life Sci. 2015;131:19–22.

    Article  CAS  PubMed  Google Scholar 

  34. French Cardiology Association (Société Française de Cardiologie). Cardiologie. Paris: Elsevier Masson; 2015.

  35. Drummond C, Gual A, Goos C, Godfrey C, Deluca P, Von Der Goltz C, et al. Identifying the gap between need and intervention for alcohol use disorders in Europe. Addiction. 2011;1:31–6.

    Article  Google Scholar 

  36. Walter FM, Usher-Smith JA, Yadlapalli S, Watson E. Caring for people living with, and beyond, cancer: an online survey of GPs in England. Br J Gen Pract. 2015;65:e761–8.

    Article  PubMed  PubMed Central  Google Scholar 

  37. McManus RJ, Wood S, Bray EP, Glasziou P, Hayen A, Heneghan C. Self-monitoring in hypertension: a web-based survey of primary care physicians. J Hum Hypertens. 2014;28:123–7.

    Article  CAS  PubMed  Google Scholar 

  38. Shih TH, Xitao F. Comparing Response Rates from Web and Mail Surveys: A Meta-Analysis. Field Methods. 2008;20:249–71.

    Article  Google Scholar 

  39. Groves RM, Presser S, Dipko S. The Role of Topic Interest in Survey Participation Decisions. Public Opin Q. 2004;68:2–31.

    Article  Google Scholar 

  40. Rehm J, Allamani A, Elekes Z, Jakubczyk A, Manthey J, Probst P, et al. Alcohol dependence and treatment utilization in Europe - a representative cross-sectional study in primary care. BMC Fam Prac. 2015;16:90.

    Article  Google Scholar 

  41. Groves RM. Survey errors and survey costs. Errors in survey costs. New York: Wiley; 1989.

    Book  Google Scholar 

  42. Friedmann PD, Rose J, Hayaki J, Ramsey S, Charuvastra A, Dubé C, et al. Training primary care clinicians in maintenance care for moderated alcohol use. J Gen Intern Med. 2006;21:1269–75.

    Article  PubMed  PubMed Central  Google Scholar 

Download references


The authors acknowledge all GP associations and all GPs who took the time to respond to the survey.


The study was financially supported by an investigator initiated grant to the first author and the GWT-TUD (Gesellschaft für Wissens- und Technologietransfer der TU Dresden mbH – company with limited liabilities for transferring knowledge and technology of the Dresden University of Technology) by Lundbeck. The study sponsor has no role in study design, collection, analysis, and interpretation of data. The study sponsor also had no role in writing of the report; and the decision to submit the paper for publication. The corresponding author confirms that the authors had full access to the data in the study at all times, and had final responsibility for the decision to submit for publication. The corresponding author hereby states that no author has been reimbursed for writing this manuscript.

Availability of data and materials

The dataset supporting the conclusions of this article is available in the figshare repository (doi:10.6084/m9.figshare.3505844), under the following link:

Authors’ contributions

JR conceptualized the study and served as PI. H-JA, CG, AG, LK, ES and JR drafted the first version of the survey and JM implemented the survey online. All authors worked on the finalization of the survey. All authors except H-JA, JM, LK, ES and JR served as site PIs and organized contacts to general practitioners in their region/country. JM combined and cleaned all collected data, and conducted the quantitative and qualitative analyses. JR wrote a first draft of the paper, and all authors contributed to and approved of the final version.

Competing interests

AG: reports grants and personal fees from Lundbeck and D&A Pharma during the conduct of the study and grants from TEVA and personal fees from Abbivie outside the submitted work.

AR: reports no conflict of interest.

BS: reports no conflict of interest.

CG: reports grants, sponsorship to attend scientific meetings, speaker honoraria and consultancy fees from Lundbeck during the conduct of the study. Consultancy fees and salaries received not related to this study received from the NHS, RCGP, Omnimedia, Pfizer, Turning Point, Locala CIC, and (all UK).

DD: reports grants from Cerin, Haute Autorité de la Santé, Ligue contre le cancer, Medtronic, Lundbeck, MSD, Novartis, Novo-Nordisk, Pfizer, and SFMG.

ES: reports sponsorship to attend scientific meetings from Lundbeck.

H-JA: reports sponsorship to attend scientific meetings, speaker honoraria and consultancy fees from Bioprojet, D&A Pharma, Ethypharm, Lundbeck, Merck-Serono, Novartis, and Pfizer.

JAAP: reports grants and personal fees from Lundbeck during the conduct of the study.

JM: reports personal fees from Lundbeck, outside of the submitted work.

JR: reports grants from Lundbeck during the conduct of this study, personal fees and serving as board member (Nalmefene) for Lundbeck.

JZ: reports personal fees from Lundbeck, and consultancy fees and salaries from Menarini, Lilly and Gilead outside of the submitted work.

LK: reports funding from Lundbeck for a research project on alcohol epidemiology unrelated to this study.

MBa: reports consulting fees received from Lundbeck (through consulting business Copentown) for organisational and process support in connection with the project. Copentown, which is owned by MB, also has other pharmaceutical/healthcare clients.

MBe: reports no direct support from Lundbeck but for foundation of BHÄV (with the aim to promote Junior GPs).

Consent for publication

Not applicable.

Ethics approval and consent to participate

This study was an anonymous survey and exempt from respective research ethics committee approval in each of the countries. All respondents were presented a brief description of the aims of the study before the actual survey started. Consent to participate was therefore a precondition of taking the survey.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Jakob Manthey.

Additional files

Additional file 1:

Structure of the questionnaire. Includes a table of all sections of the questionnaire (DOCX 17 kb)

Additional file 2:

Questionnaire. Includes the entire questionnaire implemented in the survey (DOCX 35 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rehm, J., Prieto, J.A.A., Beier, M. et al. The role of alcohol in the management of hypertension in patients in European primary health care practices – a survey in the largest European Union countries. BMC Fam Pract 17, 130 (2016).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: